Insiders KALA BIO, Inc.

Equities

KALA

US4831192020

Delayed Nasdaq Other stock markets 09:57:08 2024-05-13 EDT			5-day change	1st Jan Change
6.82 ^USD	-1.15%		-1.72%	-2.56%

04-02	HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating	MT
03-29	KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kala Pharmaceuticals Changes Name to Kala Bio	23-08-02	MT
Kala Pharmaceuticals, Inc. Announces Robert Paull Not Stands for Re-Election as A Director	23-05-11	CI
Kala Pharmaceuticals, Inc. Appoints Francis Mah as Chief Medical Advisor	23-03-29	CI
Kala Pharmaceuticals, Inc. Announces Appointment of Marjan Farid to Its Board of Directors	22-11-01	CI
Kala Pharmaceuticals, Inc. Appoints Todd Bazemore as President	21-12-20	CI
Kala Pharmaceuticals, Inc. Announces Executive Appointments	21-11-15	CI
Kala Pharmaceuticals Announces Board of Directors Changes	21-10-18	CI
Kala Pharmaceuticals, Inc Announces Resignation of Robert S. Langer as Member of the Board of Directors	18-12-20	CI
Kala Pharmaceuticals, Inc. Announces Resignation of Paulina Hill as A Member of the Board of Directors and Member of the Audit Committee	18-11-01	CI
Kala Pharmaceuticals, Inc. Appoints Steven Zhang as Vice President of Medical Affairs	18-10-25	CI
Kala Pharmaceuticals, Inc. Announces Executive Appointments	18-05-09	CI
Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary	18-04-03	CI
Kala Pharmaceuticals, Inc. Appoints Gregory Perry as Class I Director	18-03-05	CI
Kala Pharmaceuticals, Inc. Appoints Todd Bazemore as Chief Operating Officer, Effective on or About November 20, 2017	17-11-13	CI
Kala Pharmaceuticals, Inc. Appoints Andrew I. Koven to Board of Directors	17-10-02	CI
Kala Pharmaceuticals, Inc. Announces Executive Changes	17-08-11	CI
Kala Pharmaceuticals, Inc. Announces Board Appointments	16-04-13	CI
Kala Pharmaceuticals Inc Appoints Mark Iwicki as Executive Chairman and Member of the Board of Directors	15-06-23	CI
Kala Pharmaceuticals, Inc. Appoints Mark Iwicki as Executive Chairman and Member of Board of Directors	15-05-14	CI
Kala Pharmaceuticals, Inc. Names Karen Wagner to its Board of Directors	14-04-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders KALA BIO, Inc.

Equities

KALA

US4831192020

Insiders

Filters